loading

Sarepta Therapeutics Inc 주식(SRPT)의 최신 뉴스

pulisher
Sep 17, 2025

Inspire Investing LLC Purchases New Position in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Avoiding Lag: Real-Time Signals in (SRPT) Movement - news.stocktradersdaily.com

Sep 17, 2025
pulisher
Sep 17, 2025

Sarepta Therapeutics (NASDAQ:SRPT) Stock Price Up 5.2%Still a Buy? - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

The Technical Signals Behind (SRPT) That Institutions Follow - news.stocktradersdaily.com

Sep 17, 2025
pulisher
Sep 17, 2025

Sarepta Therapeutics, Inc. $SRPT Shares Acquired by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Research Analysts Offer Predictions for SRPT Q3 Earnings - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

(SRPT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Sep 17, 2025
pulisher
Sep 16, 2025

(SRPT) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Sep 16, 2025
pulisher
Sep 16, 2025

How (SRPT) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Sep 16, 2025
pulisher
Sep 16, 2025

(SRPT) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com

Sep 16, 2025
pulisher
Sep 16, 2025

Doctors Still Prescribing Sarepta’s DMD Gene Therapy After Safety Concerns - BioSpace

Sep 16, 2025
pulisher
Sep 16, 2025

Discipline and Rules-Based Execution in SRPT Response - news.stocktradersdaily.com

Sep 16, 2025
pulisher
Sep 16, 2025

Sarepta Therapeutics (NASDAQ:SRPT) Receives "Buy" Rating from Guggenheim - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Precision Trading with Sarepta Therapeutics Inc. (SRPT) Risk Zones - news.stocktradersdaily.com

Sep 16, 2025
pulisher
Sep 16, 2025

Critics call on Sarepta to show how it’s measuring gene therapy’s performance - statnews.com

Sep 16, 2025
pulisher
Sep 16, 2025

Why (SRPT) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com

Sep 16, 2025
pulisher
Sep 15, 2025

Responsive Playbooks and the SRPT Inflection - news.stocktradersdaily.com

Sep 15, 2025
pulisher
Sep 15, 2025

Q3 EPS Forecast for Sarepta Therapeutics Lifted by Analyst - MarketBeat

Sep 15, 2025
pulisher
Sep 15, 2025

(SRPT) Risk Channels and Responsive Allocation - news.stocktradersdaily.com

Sep 15, 2025
pulisher
Sep 15, 2025

Trading Systems Reacting to (SRPT) Volatility - news.stocktradersdaily.com

Sep 15, 2025
pulisher
Sep 15, 2025

Price-Driven Insight from (SRPT) for Rule-Based Strategy - news.stocktradersdaily.com

Sep 15, 2025
pulisher
Sep 15, 2025

Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth - WV News

Sep 15, 2025
pulisher
Sep 15, 2025

Using Python tools to backtest Sarepta Therapeutics Inc. strategiesJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Behavioral Patterns of SRPT and Institutional Flows - news.stocktradersdaily.com

Sep 15, 2025
pulisher
Sep 15, 2025

Sarepta Therapeutics (NASDAQ:SRPT) Given New $15.00 Price Target at Leerink Partners - MarketBeat

Sep 15, 2025
pulisher
Sep 15, 2025

How to use Fibonacci retracement on Sarepta Therapeutics Inc.Layoff News & Fast Momentum Entry Tips - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

How Sarepta Therapeutics Inc. (SRPT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Sep 14, 2025
pulisher
Sep 14, 2025

(SRPT) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Sep 14, 2025
pulisher
Sep 14, 2025

Sarepta Therapeutics Inc. stock trend outlook and recovery pathJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Scientech Research LLC Buys New Stake in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

Sep 14, 2025
pulisher
Sep 13, 2025

Trading the Move, Not the Narrative: (SRPT) Edition - news.stocktradersdaily.com

Sep 13, 2025
pulisher
Sep 13, 2025

Sarepta Gets Breathing Room in $700 Million Debt Restructure - MSN

Sep 13, 2025
pulisher
Sep 13, 2025

Liquidity Mapping Around (SRPT) Price Events - news.stocktradersdaily.com

Sep 13, 2025
pulisher
Sep 13, 2025

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Average Rating of "Hold" from Analysts - MarketBeat

Sep 13, 2025
$35.59
price down icon 0.16%
$84.92
price up icon 0.17%
$28.02
price down icon 0.12%
$99.06
price up icon 0.96%
$144.90
price up icon 0.07%
biotechnology ONC
$338.55
price up icon 2.08%
자본화:     |  볼륨(24시간):